Cargando…

Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study

BACKGROUND/AIMS: Existing therapeutic options for complicated Crohn’s disease (CD) like biologics and surgery are limited by inadequate long-term efficacy, cost, and adverse effects. Tissue hypoxia is important in CD pathogenesis and may be ameliorated with hyperbaric oxygen therapy (HBOT). We asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kante, Bhaskar, Sahu, Pabitra, Kedia, Saurabh, Vuyyuru, Sudheer K., Soni, Kapil, Singhal, Maneesh, Sharma, Raju, Makharia, Govind, Ahuja, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081995/ https://www.ncbi.nlm.nih.gov/pubmed/35124954 http://dx.doi.org/10.5217/ir.2021.00056

Ejemplares similares

Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
por: Vuyyuru, Sudheer K., et al.
Publicado: (2021)

Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2022)

Immune‐mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis
por: Vuyyuru, Sudheer K, et al.
Publicado: (2022)

Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
por: Sharma, Sanchit, et al.
Publicado: (2021)

Long‐term outcomes of anti‐tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease
por: Vuyyuru, Sudheer K, et al.
Publicado: (2021)

Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study
por: Golla, Rithvik, et al.
Publicado: (2023)

Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
por: Sachdeva, Karan, et al.
Publicado: (2023)

Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
por: Kamat, Nagesh, et al.
Publicado: (2022)

High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
por: Kante, Bhaskar, et al.
Publicado: (2023)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Development and Validation of a Smartphone Application for Telenutrition in Patients with Inflammatory Bowel Disease
por: Gupta, Arti, et al.
Publicado: (2022)

Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
por: Kumar, Peeyush, et al.
Publicado: (2023)

Differentiating Crohn’s disease from intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2019)

Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration
por: Yadav, Dawesh P., et al.
Publicado: (2017)

High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
por: Jain, Saransh, et al.
Publicado: (2021)

Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis
por: Gupta, Akshita, et al.
Publicado: (2017)

Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India
por: Harsh, Parnita, et al.
Publicado: (2017)

Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis
por: Kedia, Saurabh, et al.
Publicado: (2017)

Predictive factors for malignancy in undiagnosed isolated small bowel strictures
por: Sonika, Ujjwal, et al.
Publicado: (2017)

Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
por: Kedia, Saurabh, et al.
Publicado: (2021)

Prospective validation of CD4(+) CD25(+) FOXP3(+) T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
por: Rampal, Ritika, et al.
Publicado: (2021)

Impact of dietary beliefs and practices on patients with inflammatory bowel disease: An observational study from India
por: Tomar, Sanjeevani K, et al.
Publicado: (2017)

Does the road to primary prevention of inflammatory bowel disease start from childhood?
por: Kedia, Saurabh, et al.
Publicado: (2022)

CD4(+) CD25(+) FOXP3(+) T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease
por: Tiwari, Veena, et al.
Publicado: (2018)

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
por: Agarwal, Ashish, et al.
Publicado: (2018)

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease
por: Tomar, Sanjeevani K, et al.
Publicado: (2019)

Management of inflammatory bowel disease in older persons: evolving paradigms
por: Kedia, Saurabh, et al.
Publicado: (2018)

Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial
por: Kedia, Saurabh, et al.
Publicado: (2017)

Left‐sided colitis and extensive colitis have similar colectomy rates after index episode of acute severe colitis: A long‐term follow‐up study
por: Jain, Saransh, et al.
Publicado: (2017)

Proteome analysis of the macroscopically affected colonic mucosa of Crohn’s disease and intestinal tuberculosis
por: Rukmangadachar, Lokesh A., et al.
Publicado: (2016)

Genome-wide gene expression analysis for target genes to differentiate patients with intestinal tuberculosis and Crohn’s disease and discriminative value of FOXP3 mRNA expression
por: Ahuja, Vineet, et al.
Publicado: (2016)

Experience with Balloon Dilatation in Crohn's and Non-Crohn's Benign Small-Bowel Strictures: Is There a Difference?
por: Tsuboi, Akiyoshi, et al.
Publicado: (2019)

Small Bowel Stricture Mimicking Megacolon in a Patient with Crohn's Disease
por: Fernandes, Samuel Raimundo, et al.
Publicado: (2016)

Large Bowel Progressive Stricture after Infliximab Therapy for Crohn's Disease
por: Matsueda, Katsunori, et al.
Publicado: (2018)

A152 NATURAL HISTORY OF SMALL BOWEL STRICTURES IN CROHN’S DISEASE
por: Vu, D C, et al.
Publicado: (2022)

Fecal microbiota transplantation refurbishes the crypt-associated microbiota in ulcerative colitis
por: Markandey, Manasvini, et al.
Publicado: (2023)

Human gut microbiome: A primer for the clinician
por: Kedia, Saurabh, et al.
Publicado: (2023)

Is There True Gender Difference of Irritable Bowel Syndrome in Asia?: Author's Reply
por: Makharia, Govind K
Publicado: (2011)

An Indian national survey of therapeutic drug monitoring with anti-tumor necrosis (TNF) medications in inflammatory bowel disease
por: Patel, Rajan N., et al.
Publicado: (2020)

Biodegradable stents for the treatment of bowel strictures in Crohn's disease: technical results and challenges
por: Karstensen, John Gásdal, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_flmok15r08pgqi749gmjov7oh7